Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2014
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SUBSTITUTE
- Sponsors Sanofi
- 10 Jun 2017 Biomarkers information updated
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.